Dureach

AavantiBio

United States
NameAddress
Primghar, Iowa, United States
https://www.aavantibio.com/

Company profile

AavantiBio company profile

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

Business identity

Website
https://www.aavantibio.com/
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Founded
2020-01-01
LinkedIn

Headquarters

Headquarters
Primghar, Iowa, United States
Postal code
02142
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Total equity funding
$107M
Last funding
Series A / $107M / 2020-10-22
Last equity funding
Series A / $107M
Investors
5
Founders
2
Articles
12
Exited on
2022-09-30

Categories and groups

BiotechnologyGeneticsHealth CareLife ScienceBiotechnologyHealth CareScience and Engineering

Founders and investors

Founders

Barry ByrneManuela Corti

Investors

Bain Capital Life SciencesPerceptive AdvisorsRA Capital ManagementSarepta TherapeuticsSV Health Investors

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.